CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania

Verified interview transcripts, podcast appearances, and direct quotes from Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy at University of Pennsylvania. AI-verified speaker identity with full-text searchable transcripts.

Recent appearances

  • From Aspiring Astronaut to CAR-T Pioneer: A Journey of Serendipity with Bruce Levine, PhD

    In this episode of Scientists, Unedited, host Eirini Vamva, PhD, talks with Bruce Levine, PhD, about his personal life and career in cell therapy. Dr. Levine talks about finding his way into immunology, learning from pivotal mentors, and following the unexpected opportunities that led him to the forefront of cell therapy. He reflects on the patients who inspired his work and the teamwork behind major breakthroughs. He also shares the story behind a CAR-T song he helped write and talks about some of the things that make him who he is outside the lab, including cycling and his love of wildlife a…

    Watch on YouTube ↗

  • Bruce Levine, Co-inventor of Kymriah, University of Pennsylvania | Onyx Live | ISCT Dublin 2026

    "Pounds, kilograms of leukemia, was obliterated by their CAR-T cells over several weeks." Bruce Levine — co-inventor of Kymriah, the first ever CAR-T cell therapy — describes seeing his first patient's data come in, sixteen years ago. Now, nine years on from Kymriah's approval, approximately 10,000 patients have been treated with the cutting edge cell therapy. • Autologous and allogenic CAR-T will coexist, not replace each other. Allogenic approvals are likely in the next year or two; in vivo CAR-T offers the broadest access at the lowest cost; ex vivo autologous remains essential where deep…

    Watch on YouTube ↗

  • Behind the Eight Ball - Bruce Levine

    What can an unexpected result teach you, and how can it shape the future of an entire field? In this episode of Behind the Eight Ball, Dr. Bruce Levine - co-inventor of the first FDA-approved gene therapy, Kymriah, and one of the founding directors of the Clinical Cell and Vaccine Production Facility at the University of Pennsylvania - shares the 'behind the eight ball' moment that changed the trajectory of his work. At a critical stage in his research, Bruce encountered a surprising outcome that initially appeared to be a mistake. He reflects on how that moment forced him to question assump…

    Watch on YouTube ↗

  • ImmunoLogic, Episode 2: "Charting New Frontiers in CAR T-Cell Safety" With Bruce Levine, PhD

    We're excited to introduce another episode of the ImmunoLogic video podcast, hosted by Joseph Fraietta, PhD, an assistant professor of microbiology and the director of the Fraietta Lab at the University of Pennsylvania! Fraietta is joined by cohost Janna Minehart, MD, a clinical fellow in oncology (MSTR Program) at the University of Pennsylvania. Our hope is that this show will serve as a critical forum for clinicians, translational researchers, and biotech professionals to explore the evolving landscape of immunotherapy. We're seeking to bridge cutting-edge research with practical application…

    Watch on YouTube ↗

  • Ep186: Bruce Levine & Mags McCarthy on a Song About Science and Hope

    Bruce Levine, a CAR-T cell therapy researcher at the University of Pennsylvania, and Mags McCarthy, a country music star, discuss their new song about science and hope for cancer patients.

    Watch on YouTube ↗

  • A Decade of Impact: Tom Whitehead & Bruce Levine Reflect on CAR-T Progress & Patient Advocacy

    As the CAR-TCR Summit, and Emily Whitehead Foundation mark their 10th anniversaries, Bruce Levine, PhD, sat down with Tom Whitehead, for a conversation reflecting on a decade of CAR-T cell therapy progress, Emily's story, patient access, hopes for the future of cell therapy, and the essential role of industry collaboration in advancing patient-centered cell therapy. Find out more about the upcoming 10th CAR-TCR Summit (September 23-26, Boston) here: https://ter.li/eu4alb

    Watch on YouTube ↗

  • Dr. Bruce Levine, what if cancer isn't unbeatable? - ep01

    How can science save a life? In this first episode of "tell us your story", we meet Dr. Bruce Levine, co-inventor of the first FDA-approved CAR-T cell therapy, a revolutionary cancer treatment that changed medical history. This is the story of vision, innovation, and the very first child to survive leukemia through CAR-T therapy: Emily Whitehead. In an emotional and visually striking short documentary, we follow Bruce Levine’s journey. From early research to the groundbreaking moment that gave hope to thousands of patients worldwide. Featuring: – Bruce Levine – Amanda Finck – Emily Whitehea…

    Watch on YouTube ↗

  • ISCT TV 2025 - Interview with Bruce Levine, PhD

    Bruce Levine is the recipient of the 2025 ISCT Career Achievement Award in Cell and Gene Therapy. Hear a little bit about a moment of recent inspiration and how he helped make the song "Ring that Bell," to celebrate the resilience of both patients and the field.

    Watch on YouTube ↗

  • Amplifying Scientific Innovation®: Singer-songwriter Mags McCarthy & ⁨@penn⁩'s Dr. Bruce Levine

    Ring That Bell! Music is universal and so is scientific innovation! Celebrating the 5th Anniversary and 5th Season of the Amplifying Scientific Innovation® Video Podcast with a special episode titled, "Ring That Bell: Innovating Patient Advocacy". For the first time in the show's history, Dr. Sophia Ononye, series creator and founder & CEO of The Sophia Consulting Firm interviewed a singer-songwriter, Mags McCarthy who shared her creative approach to helping cancer patients express hope and gratitude through songs like Ring That Bell. For the second time since his Season 2 appearance back in…

    Watch on YouTube ↗

  • UCC Cancer Seminar Series - 13 Jan 2025

    The fourth lecture in this year's UCC Cancer Seminar Series was presented by Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, Perelman School of Medicine at the University of Pennsylvania and chaired by Dr Vitaliy Mykytiv. The title of Bruce Levine’s lecture is ‘From Innovation to Translation to Patients: The Future of Genetically Engineered T-Cells'.  This seminar, held on January 13th, 2025, is part of a collaborative initiative between University College Cork (UCC) and the South/Southwest Hospital Group (SSWHG), fostering knowledge exchange and collaboration in c…

    Watch on YouTube ↗

  • Navigating Cell and Gene Therapy: Insights and Challenges with Dr. Bruce Levine

    How do you navigate the complexities of manufacturing cell and gene therapies that are tailored to individual patients? Find out as we sit down with Dr. Bruce Levine from the University of Pennsylvania to unpack the intricacies of clinical research in this groundbreaking field. From the unique emphasis on chemistry, manufacturing, and controls (CMC) to the logistical hurdles of sourcing and modifying patient-derived cells, Dr. Levine offers an expert's perspective on the challenges and advancements that set these therapies apart from traditional drugs. We also shine a light on the vital role o…

    Watch on YouTube ↗

  • Dr. Bruce Levine on ISCT and the Future of CAR-T

    In anticipation of ISCT 2024 in Vancouver, Canada, Dr. Bruce Levine is back on Cell & Gene: The Podcast to share information about the event as well as his expertise on the future of CAR-T therapy for solid tumors, autoimmune disease, and more. He talks about his time and learnings as President Elect, President, and Immediate Past President of ISCT. He covers Cellicon Valley and Philadelphia's success as an on-going CGT hub, and much more. -- #celltherapy #genetherapy Subscribe to the podcast! Apple - https://podcasts.apple.com/us/podcast... Spotify - https://open.spotify.com/show/78NSjRu..…

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →